MannKind Corp
MNKD
#6316
Rank
HK$6.08 B
Marketcap
HK$19.74
Share price
-3.45%
Change (1 day)
-51.23%
Change (1 year)

Market capitalization of MannKind Corp (MNKD)

Market cap: HK$6.08 Billion

As of March 2026 MannKind Corp has a market cap of HK$6.08 Billion. This makes MannKind Corp the world's 6316th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MannKind Corp from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$6.08 B-56.03%
2025HK$13.83 B-5.26%
2024HK$14.60 B90.53%
2023HK$7.66 B-29.28%
2022HK$10.83 B26.58%
2021HK$8.56 B49.72%
2020HK$5.71 B168.75%
2019HK$2.12 B37.05%
2018HK$1.55 B-27.95%
2017HK$2.15 B-8.77%
2016HK$2.36 B-50.97%
2015HK$4.81 B-70.67%
2014HK$16.42 B10.27%
2013HK$14.89 B190.83%
2012HK$5.12 B100.83%
2011HK$2.55 B-68.18%
2010HK$8.01 B4.41%
2009HK$7.67 B183.94%
2008HK$2.70 B-57.03%
2007HK$6.29 B-33.12%
2006HK$9.40 B232.71%
2005HK$2.82 B-28.67%
2004HK$3.96 B

End of Day market cap according to different sources

On Mar 18th, 2026 the market cap of MannKind Corp was reported to be:

HK$6.29 Billion
by Nasdaq info icon info icon
HK$6.29 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
HK$1.218 T 19,930.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$1.282 T 20,982.35%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$6.447 T 105,909.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.212 T 36,284.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$58.30 B 858.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$16.31 B 168.33%๐Ÿ‡บ๐Ÿ‡ธ USA